| Metastatic heterogeneity of breast cancer: Molecular mechanism and potential therapeutic targets Y Liang, H Zhang, X Song, Q Yang Seminars in cancer biology 60, 14-27, 2020 | 763 | 2020 |
| circRNA_0025202 regulates tamoxifen sensitivity and tumor progression via regulating the miR-182-5p/FOXO3a axis in breast cancer Y Sang, B Chen, X Song, Y Li, Y Liang, D Han, N Zhang, H Zhang, Y Liu, ... Molecular Therapy 27 (9), 1638-1652, 2019 | 392 | 2019 |
| LncRNA–CDC6 promotes breast cancer progression and function as ceRNA to target CDC6 by sponging microRNA‐215 X Kong, Y Duan, Y Sang, Y Li, H Zhang, Y Liang, Y Liu, N Zhang, Q Yang Journal of cellular physiology 234 (6), 9105-9117, 2019 | 261 | 2019 |
| SREBP1, targeted by miR-18a-5p, modulates epithelial-mesenchymal transition in breast cancer via forming a co-repressor complex with Snail and HDAC1/2 N Zhang, H Zhang, Y Liu, P Su, J Zhang, X Wang, M Sun, B Chen, ... Cell Death & Differentiation 26 (5), 843-859, 2019 | 168 | 2019 |
| MiR-770 suppresses the chemo-resistance and metastasis of triple negative breast cancer via direct targeting of STMN1 Y Li, Y Liang, Y Sang, X Song, H Zhang, Y Liu, L Jiang, Q Yang Cell death & disease 9 (1), 14, 2018 | 156 | 2018 |
| circKDM4C suppresses tumor progression and attenuates doxorubicin resistance by regulating miR-548p/PBLD axis in breast cancer Y Liang, X Song, Y Li, P Su, D Han, T Ma, R Guo, B Chen, W Zhao, ... Oncogene 38 (42), 6850-6866, 2019 | 128 | 2019 |
| Epigenetic Regulation of NAMPT by NAMPT-ASDrives Metastatic Progression in Triple-Negative Breast Cancer H Zhang, N Zhang, Y Liu, P Su, Y Liang, Y Li, X Wang, T Chen, X Song, ... Cancer research 79 (13), 3347-3359, 2019 | 120 | 2019 |
| circ-EIF6 encodes EIF6-224aa to promote TNBC progression via stabilizing MYH9 and activating the Wnt/beta-catenin pathway Y Li, Z Wang, P Su, Y Liang, Z Li, H Zhang, X Song, D Han, X Wang, Y Liu, ... Molecular Therapy 30 (1), 415-430, 2022 | 117 | 2022 |
| The anticancer effect of Huaier X Song, Y Li, H Zhang, Q Yang Oncology reports 34 (1), 12-21, 2015 | 102 | 2015 |
| CircHIF1A regulated by FUS accelerates triple-negative breast cancer progression by modulating NFIB expression and translocation T Chen, X Wang, C Li, H Zhang, Y Liu, D Han, Y Li, Z Li, D Luo, N Zhang, ... Oncogene 40 (15), 2756-2771, 2021 | 79 | 2021 |
| Long noncoding RNA Linc00339 promotes triple‐negative breast cancer progression through miR‐377‐3p/HOXC6 signaling pathway X Wang, T Chen, Y Zhang, N Zhang, C Li, Y Li, Y Liu, H Zhang, W Zhao, ... Journal of Cellular Physiology 234 (8), 13303-13317, 2019 | 79 | 2019 |
| Long noncoding RNA LINP1 acts as an oncogene and promotes chemoresistance in breast cancer Y Liang, Y Li, X Song, N Zhang, Y Sang, H Zhang, Y Liu, B Chen, W Zhao, ... Cancer biology & therapy 19 (2), 120-131, 2018 | 75 | 2018 |
| Huaier extract suppresses breast cancer via regulating tumor-associated macrophages Y Li, W Qi, X Song, S Lv, H Zhang, Q Yang Scientific reports 6 (1), 20049, 2016 | 71 | 2016 |
| Hedgehog pathway is involved in nitidine chloride induced inhibition of epithelial-mesenchymal transition and cancer stem cells-like properties in breast cancer cells M Sun, N Zhang, X Wang, Y Li, W Qi, H Zhang, Z Li, Q Yang Cell & bioscience 6, 1-13, 2016 | 70 | 2016 |
| A novel long non-coding RNA-PRLB acts as a tumor promoter through regulating miR-4766-5p/SIRT1 axis in breast cancer Y Liang, X Song, Y Li, Y Sang, N Zhang, H Zhang, Y Liu, Y Duan, B Chen, ... Cell death & disease 9 (5), 563, 2018 | 69 | 2018 |
| Targeting the circBMPR2/miR-553/USP4 axis as a potent therapeutic approach for breast cancer Y Liang, X Song, Y Li, T Ma, P Su, R Guo, B Chen, H Zhang, Y Sang, ... Molecular Therapy-Nucleic Acids 17, 347-361, 2019 | 68 | 2019 |
| Prevalence and spectrum of BRCA germline variants in mainland Chinese familial breast and ovarian cancer patients YC Kim, L Zhao, H Zhang, Y Huang, J Cui, F Xiao, B Downs, SM Wang Oncotarget 7 (8), 9600, 2016 | 63 | 2016 |
| Predictive factors of nipple involvement in breast cancer: a systematic review and meta-analysis H Zhang, Y Li, MS Moran, BG Haffty, Q Yang Breast Cancer Research and Treatment 151, 239-249, 2015 | 59 | 2015 |
| circHMCU promotes proliferation and metastasis of breast cancer by sponging the let-7 family X Song, Y Liang, Y Sang, Y Li, H Zhang, B Chen, L Du, Y Liu, L Wang, ... Molecular Therapy-Nucleic Acids 20, 518-533, 2020 | 49 | 2020 |
| Comparative prognostic analysis for triple-negative breast cancer with metaplastic and invasive ductal carcinoma Y Li, N Zhang, H Zhang, Q Yang Journal of clinical pathology 72 (6), 418-424, 2019 | 45 | 2019 |
